This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grangeot-Keros, L. Articles by Hobman, T. Search for Related Content PubMed PubMed Citation Articles by Grangeot-Keros, L. Articles by Hobman, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Sep 1995, 2392-2394, Vol 33, No. 9
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles

L Grangeot-Keros, B Pustowoit and T Hobman
Department of Microbiology and Immunology, Hopital Antoine Beclere, Clamart, France.

Cobas Core Rubella IgG EIA recomb (Roche), a new, commercially available rubella enzyme immunoassay using recombinant rubella-like particles, was compared with a hemagglutination inhibition assay (Rubenosticon; Organon Teknika) and two whole-virus enzyme immunoassays (IMx [Abbott] and Platelia [Sanofi Diagnostics Pasteur]). Compared with those of these reference assays, the relative sensitivities of Cobas Core Rubella IgG recomb were 100, 94, and 95.9%, with specificities amounting to 80.8, 98, and 98.2%, respectively.

This article has been cited by other articles:

• Garbutt, M., Law, L. M. J., Chan, H., Hobman, T. C. (1999). Role of Rubella Virus Glycoprotein Domains in Assembly of Virus-Like Particles. J. Virol. 73: 3524-3533 [Abstract] [Full Text]